Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-09

Clinical Trial Update: Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating efficacy and safety of Advantan for maintenance treatment of atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Advantan

Snippet

Sponsor: LEO Pharma | Conditions: Dermatitis, Atopic | Phase 4 | Status: COMPLETED